Ledger.Open graph →
SEC Form D · Amendment · filed November 3, 2021

OncoNano Medicine, Inc

Offering
$68.4M
Sold
$68.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Southlake, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Eric W. Chan · San Francisco, CADirectorMartin Driscoll · Southlake, TXExec · DirectorJohn Dyett · Southlake, TXDirectorJeffrey R. Bartfeld · San Francisco, CADirectorBronwyn Wright · Dublin 2, IrelandExecSheldon Inwentash · Toronto, Ontario, CanadaDirectorYumin Qiu · Southlake, TXDirectorTara Iii LLC · Santa Monica, CADirectorPaul J. Hopper · New York, NYExecNoel Ford · Dublin 2, IrelandDirectorCristobal Perdomo Riveros · Ciudad de Mexico, O5DirectorScott Conway · Incline Village, NVExec · DirectorAaron I. Payas · Queensway, J1Exec · DirectorAlvaro Guillem · Southlake, TXDirectorMatthew Head · Southlake, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗